Telix Pharmaceuticals Ownership | Who Owns Telix Pharmaceuticals?

Telix Pharmaceuticals Ownership Summary

Telix Pharmaceuticals is owned by 0.76% institutional investors, and 99.24% retail investors. Fmr is the largest institutional shareholder, holding 0.17% of TLX shares. Strategic Advisers U.S. Total Stock is the top mutual fund, with 0.12% of its assets in Telix Pharmaceuticals shares.

TLX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Telix Pharmaceuticals	0.76%	-	99.24%
Sector	Healthcare Stocks	35.75%	11.89%	52.37%
Industry	Biotech Stocks	36.05%	11.82%	52.13%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	564.76K	0.17%	$5.40M
Portolan capital management	541.27K	0.16%	$5.18M
Lazard asset management	289.92K	0.09%	$2.77M
Portland investment counsel	266.20K	0.08%	$2.55M
Private advisor group	174.41K	0.05%	$1.67M
Integrated wealth concepts	164.40K	0.05%	$1.57M
Raiffeisen bank	130.00K	0.04%	$1.16M
Morgan stanley	116.44K	0.03%	$1.11M
Jpmorgan chase	57.35K	0.02%	$513.84K
Mariner	43.45K	0.01%	$415.34K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Portland investment counsel	266.20K	0.82%	$2.55M
Portolan capital management	541.27K	0.28%	$5.18M
Xy capital	12.55K	0.12%	$120.12K
Raiffeisen bank	130.00K	0.02%	$1.16M
Integrated wealth concepts	164.40K	0.01%	$1.57M
Private advisor group	174.41K	0.01%	$1.67M
Iht wealth management	25.04K	0.01%	$239.59K
Lazard asset management	289.92K	0.00%	$2.77M
Xtx topco	26.01K	0.00%	$248.89K
Vanguard personalized indexing management	33.25K	0.00%	$318.23K

Top Buyers

Holder	Shares	% Assets	Change
Portolan capital management	541.27K	0.28%	541.27K
Fmr	564.76K	0.00%	441.19K
Integrated wealth concepts	164.40K	0.01%	164.40K
Raiffeisen bank	130.00K	0.02%	130.00K
Private advisor group	174.41K	0.01%	128.07K

Top Sellers

Holder	Shares	% Assets	Change
Marshall wace, llp	-	-	-46.66K
Jane street group	-	-	-40.04K
Quadrature capital	-	-	-36.83K
Citadel advisors	-	-	-23.00K
Millennium management	-	-	-19.73K

New Positions

Holder	Shares	% Assets	Change	Value
Portolan capital management	541.27K	0.28%	541.27K	$5.18M
Integrated wealth concepts	164.40K	0.01%	164.40K	$1.57M
Raiffeisen bank	130.00K	0.02%	130.00K	$1.16M
Schonfeld strategic advisors	34.87K	0.00%	34.87K	$333.73K
Xy capital	12.55K	0.12%	12.55K	$120.12K

Sold Out

Holder	Change
True wealth design	-3.00
Principal securities	-21.00
Independence bank of kentucky	-66.00
State of wyoming	-1.29K
Hrt financial lp	-11.64K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	36	-7.69%	2,556,082	128.00%	-	684.36%	25	-7.41%	9	-
Dec 31, 2025	16	-40.74%	417,073	-49.33%	-	207.58%	12	-42.86%	2	-50.00%
Sep 30, 2025	27	28.57%	823,173	81.93%	-	1355.66%	21	10.53%	4	100.00%
Jun 30, 2025	21	250.00%	452,466	849.62%	-	64776.39%	19	280.00%	2	100.00%
Mar 31, 2025	6	500.00%	47,647	1177.40%	-	1161272.73%	5	400.00%	1	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Strategic Advisers U.S. Total Stock	404.14K	0.12%	91.85K
Lazard Digital Health	195.72K	0.06%	30.01K
BlackRock MSCI ACWI ex-US IMI Index Fd A	186.06K	0.05%	186.06K
Raiffeisen-Health&Wellbeing-ESG Akt A	130.00K	0.04%	-
Selectra J Lamarck Pharma A	14.00K	0.00%	3.00K
Lazard Digital Health J Acc USD	9.18K	0.00%	-
ActivePassive International Equity ETF	8.10K	0.00%	-
Fidelity Nasdaq Composite Index	4.69K	0.00%	1.26K
Steward Values Enhanced International I	3.94K	0.00%	3.94K
Fidelity Inst TM TPI Developed ex-NA	1.11K	0.00%	1.11K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	-
2010 Q4	-	-
2007 Q4	-	-
2007 Q3	-	-
2006 Q1	-	-

TLX Ownership FAQ

Who Owns Telix Pharmaceuticals?

Telix Pharmaceuticals shareholders are primarily institutional investors at 0.76%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Telix Pharmaceuticals's industry, Biotech Stocks , is 36.05%, which Telix Pharmaceuticals falls below.

Who owns the most shares of Telix Pharmaceuticals?

Telix Pharmaceuticals’s largest shareholders are Fmr (564.76K shares, 0.17%), Portolan capital management (541.27K shares, 0.16%), and Lazard asset management (289.92K shares, 0.09%). Together, they hold 0.41% of Telix Pharmaceuticals’s total shares outstanding.

Does Blackrock own Telix Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Telix Pharmaceuticals.

Who is Telix Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Portland investment counsel is Telix Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.82% of its assets in 266.2K Telix Pharmaceuticals shares, valued at 2.55M$.

Who is the top mutual fund holder of Telix Pharmaceuticals shares?

Strategic Advisers U.S. Total Stock is the top mutual fund holder of Telix Pharmaceuticals shares, with 0.12% of its total shares outstanding invested in 404.14K Telix Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools